Dayhista

Mebhydrolin Napadisylate is indicated in-

• Allergic disease or symptoms such as urticaria
• Pruritus of various origin
• Eczema
• Itching
• Drug rash
• Insect bites
• Allergic conjunctivitis
• Dermatitis of nutritional origin
• Hay fever,
• Vasomotor rhinitis
• Allergic asthma.

Sedating Anti-histamine

Mebhydrolin diminishes or abolishes the main actions of histamine in the body by blocking of histamine receptors.

Adults and children over 10 years: 2-6 tablets daily

Children-

• 5-10 years: 2-4 tablets daily
• 2-5 years: 1-3 tablets daily
• Up to 2 years: 1-2 tablets daily

Treatment should be given in several single doses daily. Mebhydrolin may be swallowed during or shortly after meals. For children, the tablet may be crushed and mixed with food.

Lassitude, dizziness, hypotension, muscular weakness, nausea, vomiting, diarrhoea or constipation, epigastric pain, headache, blurred vision, tinnitus, depression, nightmares, anorexia, dryness of the mouth, tightness of the chest, tingling, sedation, drowsiness etc. may occur.

The substance may cause drowsiness, if affected, driving or operating machinery & alcoholic drinks should be avoided.

The effects of atropine and tricyclic anti-depressants may be enhanced by Mebhydrolin. It may mask the warning symptoms of damage caused by ototoxic drugs.

Safety in pregnancy and lactation has not been established.

Safety in pregnancy and lactation has not been established.

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.